Forecast: Import of Alkaloids Not in Dosage Forms to the US

The forecast for the import of alkaloids not in dosage forms into the US from 2024 to 2028 indicates a steady decline in value, starting from 3.5958 million US dollars in 2024 down to 2.8628 million US dollars by 2028. This represents a consistent decrease in the demand for these imports over the forecasted years. In comparison, the value in 2023 stood at a typical level observed in 2024. The year-on-year percentage variations portray a declining trend, suggesting reductions in importation year over year, with the Compound Annual Growth Rate (CAGR) reflecting this trend downward over the five-year period.

Several trends should be watched in the future, including fluctuations in the global supply chain, changes in regulations affecting the trade of alkaloids, and advancements in pharmaceutical research that may influence the demand. Additionally, market demand shifts towards alternative sources or forms of alkaloids may significantly impact import values.